echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Long term use of new compound Daqingye tablets can cause serious adverse reactions

    Long term use of new compound Daqingye tablets can cause serious adverse reactions

    • Last Update: 2016-10-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The State Food and Drug Administration recently released the 71st "adverse drug reaction information notice", which indicated that attention should be paid to the drug risk of new compound Daqingye tablets The New Compound Folium Isatidis is a compound preparation of Chinese and Western medicine, which is composed of four chemical components: Compound Folium Isatidis extract (including Folium Isatidis, Radix Notopterygii, ginseng, honeysuckle and rhubarb), paracetamol (paracetamol), isopentobarbital, caffeine and vitamin C Its main functions are: clearing away plague, eliminating inflammation and relieving fever For cold, fever, headache, runny nose, arthralgia According to the monitoring data of adverse drug reactions in China and the relevant literature, the long-term and large-scale use of the new compound Daqingye tablet, or the combination of the new compound Daqingye tablet with other drugs containing the same components, may lead to serious allergic reactions such as severe drug eruption, as well as serious adverse reactions such as liver injury and gastrointestinal bleeding, and there are case reports leading to drug dependence The General Administration of food and drug administration has issued a notice requiring drug manufacturers to modify the instructions Relevant enterprises should improve the safety information of drug instructions as soon as possible according to the requirements, inform the medical staff and patients of the risk of new compound Daqingye tablets in an effective way, and actively carry out post market safety research to ensure the drug safety of patients The food and drug administration suggested that medical staff should inform patients to pay attention to the possible adverse reactions of new compound Daqingye tablets, avoid long-term and excessive use of drugs, and avoid combined use with drugs containing paracetamol, isopentobarbital, caffeine and other components High altitude operation, drivers, operators of fine and dangerous types of work shall be cautious.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.